Which of the following coenzyme pairs has the minimum redox potential?
Electron transport from cytochrome b to cytochrome c is inhibited by which of the following?
Which one of the following TCA cycle intermediates cannot be added or removed by other metabolic pathways?
Which of the following statement is true regarding cyanide?
Which substance inhibits cytochrome oxidase in oxidative phosphorylation?
Transport of ADP in and ATP out of mitochondria is inhibited by which substance?
Mitochondria are involved in all except:
Fireflies produce light due to which molecule?
All the following inhibit complex IV and totally arrest respiration except?
Which component of the respiratory chain reacts directly with molecular oxygen?
Explanation: **Explanation:** In the Electron Transport Chain (ETC), electrons flow from carriers with a **more negative (lower) redox potential** to those with a **more positive (higher) redox potential**. The redox potential ($E_0'$) is a measure of the affinity of a substance for electrons; the more negative the value, the greater the tendency to donate electrons. **Why NAD+/NADH is correct:** Among the options provided, the **NAD+/NADH** pair has the lowest (most negative) redox potential, approximately **-0.32 V**. This makes NADH the primary electron donor at the start of the respiratory chain (Complex I). Because it sits at the "top" of the energy gradient, the transfer of electrons from NADH to Oxygen (the final acceptor) releases the maximum amount of free energy, sufficient to pump protons at three different complexes (I, III, and IV). **Analysis of Incorrect Options:** * **NADP+/NADPH:** While it has a similar redox potential to NAD+/NADH (-0.32 V), it is primarily used for **reductive biosynthesis** (e.g., fatty acid synthesis) rather than ATP production in the ETC. In the context of the respiratory chain and standard metabolic energy production questions, NAD+ is the standard reference for the minimum potential. * **FAD/FADH2:** This pair has a redox potential of approximately **-0.22 V**. Since it is more positive than NAD+, it enters the ETC at Complex II, bypassing the first proton pump and resulting in less ATP yield. * **CoQ/CoQH2 (Ubiquinone):** This pair has a redox potential of approximately **+0.06 V**. It acts as a mobile collector of electrons from both Complex I and Complex II, passing them toward Complex III. **High-Yield Clinical Pearls for NEET-PG:** * **The Gradient:** Electrons always flow from the most negative potential (NADH) to the most positive potential (Oxygen, $+0.82\text{ V}$). * **ATP Yield:** The "P:O ratio" for NADH is ~2.5, while for FADH2 it is ~1.5, directly due to the difference in their starting redox potentials. * **Inhibitors:** Rotenone inhibits the transfer from NADH to CoQ, while Cyanide and CO inhibit the final step (Complex IV) where redox potential is highest.
Explanation: ### Explanation The Electron Transport Chain (ETC) consists of four major protein complexes located in the inner mitochondrial membrane. The flow of electrons through these complexes is essential for creating the proton gradient used in ATP synthesis. **Correct Answer: B. Antimycin** Antimycin (specifically Antimycin A) is a potent inhibitor of **Complex III** (Cytochrome $bc_1$ complex). It binds to the $Q_i$ site of the complex, effectively blocking the transfer of electrons from **Cytochrome $b$ to Cytochrome $c_1$**. This halt in electron flow prevents the reduction of Cytochrome $c$, thereby stopping the entire respiratory chain. **Analysis of Incorrect Options:** * **A. Oligomycin:** This is an inhibitor of **ATP Synthase (Complex V)**. It binds to the $F_o$ subunit, blocking the proton channel and preventing the phosphorylation of ADP to ATP. It does not directly inhibit the electron transfer between cytochromes. * **C. Piericidin:** Like Rotenone and Amobarbital, Piericidin inhibits **Complex I** (NADH-Q oxidoreductase). It prevents the transfer of electrons from NADH to Coenzyme Q. * **D. Carbon monoxide (CO):** CO, along with Cyanide ($CN^-$) and Sodium Azide ($NaN_3$), inhibits **Complex IV** (Cytochrome $c$ oxidase). It binds to the heme $a_3$ site, preventing the final transfer of electrons to oxygen. **High-Yield Clinical Pearls for NEET-PG:** * **Complex I Inhibitors:** Rotenone, Piericidin A, Amobarbital (Amytal). * **Complex II Inhibitors:** Carboxin, Malonate (competitive inhibitor of Succinate Dehydrogenase). * **Complex III Inhibitors:** Antimycin A, British Anti-Lewisite (BAL). * **Complex IV Inhibitors:** Cyanide, CO, Azide, $H_2S$. * **Uncouplers:** 2,4-Dinitrophenol (DNP), Thermogenin (brown fat), high-dose Aspirin. These dissipate the proton gradient as heat without inhibiting the ETC itself.
Explanation: **Explanation:** The TCA (Tricarboxylic Acid) cycle is an amphibolic pathway, meaning it serves both catabolic and anabolic functions. Most intermediates act as "metabolic hubs" that can enter or exit the cycle via **anaplerotic** (filling up) or **cataplerotic** (depleting) reactions. **Why Isocitrate is the Correct Answer:** Isocitrate is the only intermediate listed that does not have a direct alternative metabolic pathway for its synthesis or utilization outside of the TCA cycle (and the glyoxylate shunt in plants/bacteria, which is absent in humans). It is formed solely from citrate via aconitase and is immediately converted to alpha-ketoglutarate. Therefore, it cannot be "added or removed" by other human metabolic pathways. **Analysis of Incorrect Options:** * **Oxaloacetate:** A major metabolic hub. It can be synthesized from pyruvate (via pyruvate carboxylase) or transaminated from **Aspartate**. It is also a key substrate for gluconeogenesis. * **Citrate:** Can be transported out of the mitochondria into the cytosol, where it is cleaved by ATP-citrate lyase to provide Acetyl-CoA for **fatty acid synthesis**. * **Fumarate:** Produced in the **Urea Cycle**, the glucose-alanine cycle, and during the catabolism of amino acids like Phenylalanine and Tyrosine. **High-Yield NEET-PG Pearls:** * **Anaplerosis:** The most important anaplerotic reaction in the liver is the carboxylation of pyruvate to oxaloacetate by **pyruvate carboxylase** (requires Biotin). * **Rate-Limiting Step:** Isocitrate dehydrogenase is the rate-limiting enzyme of the TCA cycle; it is inhibited by ATP and NADH, and activated by ADP and $Ca^{2+}$. * **Succinate Dehydrogenase:** The only TCA cycle enzyme located in the inner mitochondrial membrane (part of Complex II of ETC); all others are in the matrix.
Explanation: **Explanation:** **1. Why the Correct Answer is Right:** Cyanide is a potent inhibitor of the **Electron Transport Chain (ETC)**. It acts specifically on **Complex IV (Cytochrome c oxidase)**. Cyanide has a high affinity for the **ferric (Fe³⁺) state** of the heme iron in **cytochrome a3**. By binding to this site, it prevents the final transfer of electrons to oxygen (the terminal electron acceptor). This halts the entire mitochondrial respiratory chain, leading to a rapid cessation of ATP production and cellular hypoxia despite adequate oxygen supply. **2. Why the Incorrect Options are Wrong:** * **Option A:** Cyanide is a lethal inhibitor, not a minimal one. Because cytochrome oxidase is the terminal step, its inhibition causes a "backup" of the entire chain, completely stopping aerobic respiration. * **Option B:** Mitochondrial respiration and energy production (ATP) are inextricably linked via oxidative phosphorylation. If respiration is inhibited, the proton gradient collapses, and ATP production stops. * **Option C:** While cytochrome oxidase contains copper ions ($Cu_A$ and $Cu_B$), cyanide primarily exerts its toxic effect by binding to the **iron (Fe³⁺)** of cytochrome a3. Carbon monoxide (CO), conversely, binds to the ferrous (Fe²⁺) state. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Antidote Mechanism:** Amyl nitrite/Sodium nitrite is used to induce **methemoglobinemia**. Methemoglobin contains $Fe^{3+}$, which acts as a "decoy" to sequester cyanide away from cytochrome a3. * **Specific Antidote:** **Hydroxocobalamin** (Vitamin B12 precursor) binds cyanide to form non-toxic cyanocobalamin. * **Key Distinctions:** * **Cyanide/Azide:** Bind $Fe^{3+}$ of Cytochrome a3. * **Carbon Monoxide (CO):** Binds $Fe^{2+}$ of Cytochrome a3. * **Rotenone:** Inhibits Complex I. * **Antimycin A:** Inhibits Complex III. * **Oligomycin:** Inhibits $F_0$ subunit of ATP synthase (Complex V).
Explanation: **Explanation:** The correct answer is **Carbon monoxide (CO)**. Oxidative phosphorylation occurs in the inner mitochondrial membrane via the Electron Transport Chain (ETC). **Cytochrome oxidase (Complex IV)** is the terminal enzyme of this chain, responsible for transferring electrons to oxygen to form water. Carbon monoxide (CO) binds to the heme iron in Complex IV, preventing oxygen from binding, thus halting ATP production and causing cellular hypoxia. **Analysis of Options:** * **Carbon monoxide (CO) & Cyanide (CN⁻):** Both are potent inhibitors of **Complex IV**. They bind to the $Fe^{3+}$ (ferric) or $Fe^{2+}$ (ferrous) states of the heme group in cytochrome $a_3$. * **Hydrogen sulfide ($H_2S$):** While $H_2S$ also inhibits Complex IV, in the context of standard medical examinations and the specific wording of this question, CO and Cyanide are the primary classical inhibitors tested. (Note: Some textbooks list $H_2S$ as an inhibitor, but CO is the most frequent "correct" choice in this specific MCQ set). * **Rotenone:** This is a classic inhibitor of **Complex I** (NADH-Q oxidoreductase). It is commonly used as an insecticide. * **Amobarbital (Amytal):** A barbiturate that also inhibits **Complex I**, preventing the transfer of electrons from Fe-S centers to Ubiquinone. **High-Yield Clinical Pearls for NEET-PG:** * **Complex I Inhibitors:** Rotenone, Amobarbital, Piericidin A. * **Complex II Inhibitors:** Malonate (competitive inhibitor of Succinate Dehydrogenase), Carboxin. * **Complex III Inhibitors:** Antimycin A, British Anti-Lewisite (BAL). * **Complex IV Inhibitors:** CO, Cyanide, Azide, $H_2S$. * **Complex V (ATP Synthase) Inhibitor:** Oligomycin (blocks the $F_0$ proton channel). * **Uncouplers:** 2,4-Dinitrophenol (DNP), Thermogenin (Brown fat), Aspirin (overdose). These dissipate the proton gradient, increasing $O_2$ consumption while decreasing ATP synthesis.
Explanation: ### Explanation **Correct Answer: A. Atractyloside** The transport of ADP into the mitochondrial matrix and ATP out into the cytosol is mediated by the **Adenine Nucleotide Translocase (ANT)**, also known as the ADP/ATP carrier. This is an antiporter located in the inner mitochondrial membrane. **Atractyloside**, a plant toxin derived from the Mediterranean thistle (*Atractylis gummifera*), specifically binds to the ANT when its binding site is facing the intermembrane space, thereby inhibiting the exchange of ADP and ATP. This halts the supply of ADP for ATP synthase, effectively stopping oxidative phosphorylation. Another inhibitor of this translocator is **Bongkrekic acid**, which binds when the site faces the matrix. **Why the other options are incorrect:** * **B. Oligomycin:** This is an inhibitor of **ATP Synthase (Complex V)**. It binds to the $F_o$ subunit, blocking the proton channel and preventing the phosphorylation of ADP to ATP. * **C. Rotenone:** This is a classic inhibitor of **Complex I (NADH-Q oxidoreductase)** of the Electron Transport Chain (ETC). It prevents the transfer of electrons from NADH to Coenzyme Q. * **D. Cyanide:** This is a potent inhibitor of **Complex IV (Cytochrome c oxidase)**. It binds to the ferric iron ($Fe^{3+}$) in heme $a_3$, completely arresting the ETC and cellular respiration. **High-Yield Clinical Pearls for NEET-PG:** * **Inhibitors vs. Uncouplers:** Inhibitors (like those above) stop both the ETC and ATP synthesis. Uncouplers (like 2,4-DNP) stop ATP synthesis but actually *increase* the rate of the ETC and oxygen consumption, dissipating energy as heat. * **Bongkrekic acid:** Often tested alongside Atractyloside; it is found in contaminated fermented coconut (Tempe bongkrek). * **Ionophores:** Valinomycin (transports $K^+$) and Gramicidin (transports $Na^+/K^+$) also disrupt the mitochondrial membrane potential.
Explanation: **Explanation:** The correct answer is **Fatty acid synthesis** because this metabolic process occurs primarily in the **cytosol**, not the mitochondria. 1. **Why Fatty Acid Synthesis is the correct answer:** While the precursor (Acetyl-CoA) is generated in the mitochondria, it must be transported to the cytosol as Citrate. The actual assembly of long-chain fatty acids by the Fatty Acid Synthase (FAS) multienzyme complex occurs exclusively in the **cytosol**. 2. **Analysis of Incorrect Options:** * **DNA Synthesis:** Mitochondria are unique organelles containing their own circular, double-stranded DNA (**mtDNA**). They possess the machinery for independent DNA replication and protein synthesis. * **Citric Acid Cycle (TCA Cycle):** This is the central hub of aerobic metabolism. All enzymes of the TCA cycle (except succinate dehydrogenase, which is on the inner membrane) are located in the **mitochondrial matrix**. * **Fatty acid β-oxidation:** This is the catabolic process of breaking down fatty acids to generate energy. It occurs within the **mitochondrial matrix** (after the carnitine shuttle transports the acyl groups across the membrane). **High-Yield Clinical Pearls for NEET-PG:** * **Metabolic Compartmentalization:** Remember the "Two-Sided" pathways. **Heme synthesis, Urea cycle, and Gluconeogenesis** occur in both the mitochondria and cytosol. * **Mitochondrial Inheritance:** mtDNA is inherited exclusively from the **mother**. * **Key Marker Enzyme:** **Succinate dehydrogenase** is a marker enzyme for the inner mitochondrial membrane and is also part of Complex II of the Electron Transport Chain.
Explanation: **Explanation:** The production of light by living organisms, known as **bioluminescence**, is a process that converts chemical energy into light energy. In fireflies, this reaction occurs within specialized cells called photocytes. **Why ATP is Correct:** The reaction is catalyzed by the enzyme **luciferase**. The process occurs in two steps: 1. **Activation:** Luciferin reacts with **ATP** to form luciferyl-adenylate and pyrophosphate (PPi). This step is crucial as it "primes" the molecule. 2. **Oxidation:** The luciferyl-adenylate then reacts with oxygen to produce oxyluciferin and light. Without ATP, the initial activation of luciferin cannot occur, making ATP the essential energy currency for this biological light production. **Why Other Options are Incorrect:** * **NADH:** While NADH is a major electron donor in the respiratory chain for ATP production, it does not directly provide the phosphate-bond energy required for the luciferase reaction. * **GTP:** GTP is primarily involved in protein synthesis and signal transduction (G-proteins). It is not the substrate for the firefly luciferase enzyme. * **Phosphocreatinine:** This is a high-energy storage compound used primarily in muscle and brain tissue to rapidly regenerate ATP; it is not directly consumed in bioluminescence. **High-Yield NEET-PG Pearls:** * **Luciferase Assay:** In medical research, the firefly luciferase gene is used as a **"Reporter Gene"** to study gene expression. * **ATP Detection:** Because the reaction is strictly ATP-dependent, luciferase is used in labs to quantify the amount of ATP present in biological samples (an indicator of cell viability). * **Energy Requirement:** Bioluminescence is an **endergonic** process that requires the hydrolysis of ATP to AMP and PPi.
Explanation: **Explanation:** The Electron Transport Chain (ETC) is the final common pathway in aerobic respiration. **Complex IV (Cytochrome c oxidase)** is the terminal enzyme that transfers electrons to oxygen. Inhibition of this complex is lethal as it completely arrests cellular respiration. **Why Dimercaprol is the correct answer:** Dimercaprol (British Anti-Lewisite or BAL) is a chelating agent used in the treatment of heavy metal poisoning (e.g., arsenic, mercury, lead). It does **not** inhibit Complex IV. Instead, it acts as an inhibitor of **Complex III** (Cytochrome bc1 complex) by competing with ubiquinone. Since the question asks for inhibitors of Complex IV, Dimercaprol is the exception. **Analysis of Incorrect Options (Complex IV Inhibitors):** * **Cyanide (CN⁻):** Binds to the ferric iron ($Fe^{3+}$) in the heme group of Cytochrome $a_3$, preventing oxygen reduction. * **Carbon Monoxide (CO):** Binds to the ferrous iron ($Fe^{2+}$) in Cytochrome $a_3$. It competes with oxygen, particularly when oxygen tension is low. * **Hydrogen Sulfide ($H_2S$):** A potent inhibitor that binds to the active site of Complex IV, similar to cyanide, often encountered in industrial toxicity. * **Azide ($N_3^-$):** (Additional fact) Also inhibits Complex IV. **High-Yield Clinical Pearls for NEET-PG:** * **Complex I Inhibitors:** Rotenone, Amobarbital (Amytal), Piericidin A. * **Complex II Inhibitors:** Malonate (competitive inhibitor of Succinate Dehydrogenase), Carboxin. * **Complex III Inhibitors:** Antimycin A, Dimercaprol. * **Complex V (ATP Synthase) Inhibitor:** Oligomycin (closes the $F_0$ proton channel). * **Uncouplers:** 2,4-Dinitrophenol (DNP), Thermogenin (brown fat), high-dose Aspirin. These increase oxygen consumption but decrease ATP synthesis.
Explanation: **Explanation:** The respiratory chain (Electron Transport Chain) consists of a series of protein complexes located in the inner mitochondrial membrane. The final step of this chain involves the transfer of electrons to molecular oxygen ($O_2$), the terminal electron acceptor. **Why Cytochrome $aa_3$ is correct:** Cytochrome $aa_3$, also known as **Complex IV** or **Cytochrome c Oxidase**, is the only component of the respiratory chain that can react directly with molecular oxygen. It contains two copper centers ($Cu_A$ and $Cu_B$) and two heme groups ($a$ and $a_3$). Cytochrome $a_3$ and $Cu_B$ form a binuclear center that binds $O_2$ and reduces it to two molecules of water ($H_2O$). **Why other options are incorrect:** * **Cytochrome b:** Part of Complex III (Cytochrome $bc_1$ complex). it transfers electrons from Coenzyme Q to Cytochrome c. * **Coenzyme Q (Ubiquinone):** A mobile lipid-soluble electron carrier that shuttles electrons from Complexes I and II to Complex III. * **Cytochrome c:** A small peripheral membrane protein that shuttles electrons between Complex III and Complex IV. It does not have the redox potential or structural site to bind oxygen. **High-Yield NEET-PG Pearls:** * **Inhibitors of Complex IV:** Cyanide ($CN^-$), Carbon Monoxide ($CO$), Hydrogen Sulfide ($H_2S$), and Azide ($N_3^-$) bind to the iron in cytochrome $aa_3$, halting ATP production. * **P/O Ratio:** For every NADH oxidized, 2.5 ATP are formed; for every $FADH_2$, 1.5 ATP are formed. * **Complex IV** is the site where the "metabolic water" is produced.
Bioenergetics and Thermodynamics
Practice Questions
ATP as Energy Currency
Practice Questions
Tricarboxylic Acid Cycle
Practice Questions
Electron Transport Chain
Practice Questions
Oxidative Phosphorylation
Practice Questions
Mitochondrial Diseases
Practice Questions
Uncouplers and Inhibitors of Oxidative Phosphorylation
Practice Questions
Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate
Practice Questions
Energy Yield from Nutrients
Practice Questions
Metabolic Rate and Basal Metabolism
Practice Questions
Brown Adipose Tissue and Thermogenesis
Practice Questions
Oxygen Toxicity and Free Radicals
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free